2025
Prediction of Hepatitis C Virus Perinatal Transmission in Pregnant Individuals With Hepatitis C Virus Infection
Sandoval G, Saade G, Hughes B, Clifton R, Reddy U, Bartholomew A, Salazar A, Chien E, Tita A, Thorp J, Metz T, Wapner R, Sabharwal V, Simhan H, Swamy G, Heyborne K, Sibai B, Grobman W, El-Sayed Y, Casey B, Parry S, Macones G, Prasad M. Prediction of Hepatitis C Virus Perinatal Transmission in Pregnant Individuals With Hepatitis C Virus Infection. Obstetrics And Gynecology 2025, 145: 449-452. PMID: 40014859, PMCID: PMC11925659, DOI: 10.1097/aog.0000000000005872.Peer-Reviewed Original ResearchMeSH KeywordsAdultFemaleHepacivirusHepatitis CHumansInfant, NewbornInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, InfectiousRNA, ViralYoung AdultConceptsHepatitis C virus infectionPerinatal transmissionHepatitis C virusHepatitis C virus perinatal transmissionPregnant individualsEunice Kennedy Shriver National Institute of Child HealthTransmission of HCV infectionPerinatal transmission rateHCV RNA titersNeonatal follow-upC virus infectionPositive HCV antibodyMulticenter observational studyArea under the curveNational Institute of Child HealthInstitute of Child HealthAntibody-positive participantsAntepartum bleedingHCV infectionHCV antibodiesFollow-upRNA titersC virusObservational studyClinical counseling
2024
Positive Autism Screening Rates in Toddlers Born During the COVID-19 Pandemic
Firestein M, Manessis A, Warmingham J, Xu R, Hu Y, Finkel M, Kyle M, Hussain M, Ahmed I, Lavallée A, Solis A, Chaves V, Rodriguez C, Goldman S, Muhle R, Lee S, Austin J, Silver W, O’Reilly K, Bain J, Penn A, Veenstra-VanderWeele J, Stockwell M, Fifer W, Marsh R, Monk C, Shuffrey L, Dumitriu D. Positive Autism Screening Rates in Toddlers Born During the COVID-19 Pandemic. JAMA Network Open 2024, 7: e2435005. PMID: 39312236, PMCID: PMC11420691, DOI: 10.1001/jamanetworkopen.2024.35005.Peer-Reviewed Original ResearchConceptsElectronic health recordsCOVID-19 Mother Baby OutcomesM-CHAT-RScreening ratesPandemic exposureMaternal SARS-CoV-2 infectionCohort studyColumbia University Irving Medical CenterMaternal SARS-CoV-2 statusLogistic regression modelsPrenatal exposureSARS-CoV-2 infectionHealth recordsProspective longitudinal studyModified checklistMain OutcomesClinical careBaby outcomeSARS-CoV-2 statusNew York CityPrimary outcomeScreen-positiveMedical CenterPrimary analysisGroup of childrenSafety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies
Getahun D, Liu I, Sy L, Glanz J, Zerbo O, Vazquez-Benitez G, Nelson J, Williams J, Hambidge S, McLean H, Irving S, Weintraub E, Qian L. Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies. JAMA Network Open 2024, 7: e2434857. PMID: 39298167, PMCID: PMC11413712, DOI: 10.1001/jamanetworkopen.2024.34857.Peer-Reviewed Original ResearchMeSH KeywordsAdultFemaleHumansInfant, NewbornInfluenza VaccinesInfluenza, HumanPregnancyPregnancy Complications, InfectiousPregnancy OutcomePremature BirthRetrospective StudiesSeasonsVaccinationYoung AdultConceptsAdverse perinatal outcomesPreterm premature rupture of membranesPremature rupture of membranesPreterm premature ruptureRupture of membranesRisk of preeclampsiaSeasonal influenza vaccineInfluenza vaccineAssociated with increased riskInterpregnancy intervalPerinatal outcomesVaccine typesPlacental abruptionPreterm birthInfluenza seasonAssociated with increased risk of preeclampsiaCohort studyRisk of adverse perinatal outcomesAssociated with increased risk of adverse perinatal outcomesSingleton live birth pregnanciesRelative riskLive-birth pregnanciesGestational age birthsRetrospective cohort studyAdjusted relative risksComparative Analysis of Viral Load and Cytokines during SARS-CoV-2 Infection between Pregnant and Non-Pregnant Women
Liu D, Li H, Li X, Rodriguez G, Pietz H, Fiel R, Konadu E, Singh V, Loo F, Rodgers W. Comparative Analysis of Viral Load and Cytokines during SARS-CoV-2 Infection between Pregnant and Non-Pregnant Women. International Journal Of Molecular Sciences 2024, 25: 7731. PMID: 39062978, PMCID: PMC11277191, DOI: 10.3390/ijms25147731.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntibodies, NeutralizingAntibodies, ViralCOVID-19CytokinesFemaleHumansImmunoglobulin GPregnancyPregnancy Complications, InfectiousRetrospective StudiesSARS-CoV-2Spike Glycoprotein, CoronavirusViral LoadConceptsNon-pregnant womenSARS-CoV-2 infectionResponse to SARS-CoV-2 infectionPregnant womenViral loadNeutralizing antibodiesImmune response to SARS-CoV-2 infectionAnalysis of viral loadSARS-CoV-2Retrospective cohort studyIgG neutralizing antibodiesCytokine expression patternsMultiplex reverse transcription polymerase chain reactionAnti-N protein IgGExpression of leptinDifferential cytokine expressionEnhanced antibody productionReverse transcription polymerase chain reactionVulnerability of pregnant womenCytokine array assayTranscription polymerase chain reactionCytokine profileIncidence of SARS-CoV-2 infectionImmune modulationPolymerase chain reactionNonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes
Son M, Riley L, Staniczenko A, Cron J, Yen S, Thomas C, Sholle E, Osborne L, Lipkind H. Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes. JAMA Network Open 2024, 7: e2419268. PMID: 38976271, PMCID: PMC11231799, DOI: 10.1001/jamanetworkopen.2024.19268.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusNeonatal intensive care unitPreterm birthWeeks gestationRisk of HDPPerinatal outcomesLogistic regression modelsIncreased riskPregnant individualsPrenatal vaccinationSmall-for-gestational age birth weightNeonatal intensive care unit admissionCohort studyIncreased risk of PTBOdds ratioIncreased risk of HDPRisk of preterm birthRespiratory syncytial virus seasonRespiratory syncytial virus vaccineRetrospective observational cohort studyNeonatal respiratory distressVaccination statusMultivariate logistic regression modelObservational cohort studyCox regression modelsObstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination
Vesco K, Denoble A, Lipkind H, Kharbanda E, DeSilva M, Daley M, Getahun D, Zerbo O, Naleway A, Jackson L, Williams J, Boyce T, Fuller C, Weintraub E, Vazquez-Benitez G. Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics And Gynecology 2024, 143: 794-802. PMID: 38626447, PMCID: PMC11090513, DOI: 10.1097/aog.0000000000005583.Peer-Reviewed Original ResearchMeSH KeywordsAdultCOVID-19COVID-19 VaccinesFemaleHumansInfant, NewbornInfant, Small for Gestational AgePregnancyPregnancy Complications, InfectiousPregnancy OutcomePremature BirthRetrospective StudiesSARS-CoV-2VaccinationYoung AdultConceptsSmall-for-gestational ageMessenger RNA COVID-19 vaccineGestational diabetes mellitusRisk of adverse pregnancy outcomesAdverse pregnancy outcomesPreterm birthGestational hypertensionAdjusted hazard ratiosCOVID-19 vaccine dosesPregnancy outcomesCOVID-19 vaccineAssociated with small-for-gestational ageIncreased risk of adverse pregnancy outcomesVaccine doseRisk of preterm birthMessenger RNARetrospective cohort study of individualsMRNA COVID-19 vaccineWeeks of gestationRetrospective cohort studyHistory of COVID-19Cohort study of individualsVaccine Safety DatalinkSingleton pregnanciesUnexposed pregnancies
2023
Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection — 2-Year Outcomes
Hughes B, Clifton R, Rouse D, Saade G, Dinsmoor M, Reddy U, Pass R, Allard D, Mallett G, MacPherson C, Wapner R, Metz T, Goodnight W, Tita A, Costantine M, Swamy G, Heyborne K, Chien E, Chauhan S, El-Sayed Y, Casey B, Parry S, Simhan H, Napolitano P, Macones G. Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection — 2-Year Outcomes. New England Journal Of Medicine 2023, 389: 1822-1824. PMID: 37937785, PMCID: PMC10683876, DOI: 10.1056/nejmc2308286.Peer-Reviewed Original ResearchMeSH KeywordsCytomegalovirus InfectionsFemaleHumansImmunoglobulinsImmunoglobulins, IntravenousPregnancyPregnancy Complications, InfectiousTreatment OutcomeGroup B streptococcus colonization in pregnancy and neighborhood socioeconomic disadvantage
Bank T, Yee L, Lynch C, Wu J, Johnson J, McNeil R, Mercer B, Simhan H, Reddy U, Silver R, Parry S, Saade G, Chung J, Wapner R, Grobman W, Venkatesh K. Group B streptococcus colonization in pregnancy and neighborhood socioeconomic disadvantage. American Journal Of Obstetrics And Gynecology 2023, 229: 564-566.e7. PMID: 37487854, DOI: 10.1016/j.ajog.2023.07.028.Peer-Reviewed Original ResearchAntibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes
Snider J, Mithal L, Kwah J, Rhodes N, Son M. Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes. BMC Pregnancy And Childbirth 2023, 23: 400. PMID: 37254067, PMCID: PMC10228028, DOI: 10.1186/s12884-023-05697-0.Peer-Reviewed Original ResearchConceptsGroup B streptococcus prophylaxisReported penicillin allergyPenicillin allergyGBS prophylaxisLab drawsNeonatal outcomesNewborn outcomesAntibiotic administrationMedical recordsPregnant individualsIntrapartum group B streptococcus prophylaxisNeonatal intensive care unit admissionDesignThis retrospective cohort studyIntensive care unit admissionSelf-reported penicillin allergyNeonates of mothersCare unit admissionIntrapartum antibiotic prophylaxisRetrospective cohort studyWeeks of gestationMother-infant pairsMother-infant dyadsBeta-lactam antibioticsAntibiotic prophylaxisUnit admissionOutcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)
Tuan J, Sharma M, Kayani J, Davis M, McManus D, Topal J, Ogbuagu O. Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO). BMC Infectious Diseases 2023, 23: 258. PMID: 37101135, PMCID: PMC10130811, DOI: 10.1186/s12879-023-08198-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntibodies, Monoclonal, HumanizedBNT162 VaccineCOVID-19FemaleHumansInfant, NewbornPregnancyPregnancy Complications, InfectiousPregnant PeopleSARS-CoV-2ConceptsCOVID-19 patientsPregnant womenClinical outcomesEmergency departmentPositive SARS-CoV-2 testAdverse feto-maternal outcomesIntensive care unit admissionMild-moderate COVID-19Pregnant COVID-19 patientsPrimary composite clinical outcomeSARS-CoV-2 testComplete primary vaccinationComposite clinical outcomeCare unit admissionFeto-maternal outcomeMedical record reviewSARS-CoV-2 treatmentBetter clinical outcomesBody mass indexSickle cell diseaseCOVID-19SARS-CoV-2Neonatal complicationsPrimary vaccinationUnit admissionMaternal SARS-CoV-2, Placental Changes and Brain Injury in 2 Neonates
Benny M, Bandstra E, Saad A, Lopez-Alberola R, Saigal G, Paidas M, Jayakumar A, Duara S. Maternal SARS-CoV-2, Placental Changes and Brain Injury in 2 Neonates. Pediatrics 2023, 151: e2022058271. PMID: 37021494, PMCID: PMC10467358, DOI: 10.1542/peds.2022-058271.Peer-Reviewed Original ResearchMeSH KeywordsBrain InjuriesCOVID-19FemaleGlycoproteinsHumansInfant, NewbornInfectious Disease Transmission, VerticalNucleocapsid ProteinsPlacentaPregnancyPregnancy Complications, InfectiousSARS-CoV-2ConceptsSARS-CoV-2SARS-CoV-2 infectionBrain injuryFetal brainSevere acute respiratory syndrome coronavirus disease 2Detectable SARS-CoV-2 antibodiesMaternal SARS-CoV-2 infectionSARS-CoV-2-positive mothersLong-term neurodevelopmental sequelaeMaternal SARS-CoV-2SARS-CoV-2 antibodiesStromal cell-derived factor-1Sudden unexpected infant deathInfant brainCell-derived factor-1Fetal vascular malperfusionSevere parenchymal atrophyHypoxic-ischemic encephalopathyBlood inflammatory markersUnexpected infant deathEarly-onset seizuresHuman chorionic gonadotropinOxidative stress injuryMonths of ageSARS-CoV-2 nucleocapsid proteinAssessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy
Firestein M, Shuffrey L, Hu Y, Kyle M, Hussain M, Bianco C, Hott V, Hyman S, Kyler M, Rodriguez C, Romero M, Lopez H, Alcántara C, Amso D, Austin J, Bain J, Barbosa J, Battarbee A, Bruno A, Ettinger S, Factor-Litvak P, Gilboa S, Goldman S, Gyamfi-Bannerman C, Maniatis P, Marsh R, Morrill T, Mourad M, Muhle R, Newes-Adeyi G, Noble K, O’Reilly K, Penn A, Reichle L, Sania A, Semenova V, Silver W, Smotrich G, Tita A, Tottenham N, Varner M, Welch M, Zork N, Garey D, Fifer W, Stockwell M, Monk C, Dawood F, Dumitriu D. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Network Open 2023, 6: e237396. PMID: 37036706, PMCID: PMC10087058, DOI: 10.1001/jamanetworkopen.2023.7396.Peer-Reviewed Original ResearchMeSH KeywordsAdultChildChild, PreschoolCohort StudiesCOVID-19Cross-Sectional StudiesFemaleHumansInfantInfant, NewbornMalePregnancyPregnancy Complications, InfectiousPrenatal Exposure Delayed EffectsProspective StudiesSARS-CoV-2ConceptsMaternal SARS-CoV-2 infectionSARS-CoV-2 infectionInfant neurodevelopmentPrenatal exposureCohort studyNeurodevelopmental outcomesPregnant individualsMild SARS-CoV-2 infectionAsymptomatic SARS-CoV-2 infectionGross motorFine motorMultisite prospective cohort studySubdomain scoresSARS-CoV-2 exposureProspective cross-sectional studyAssessment of neurodevelopmentProspective cohort studyInfant neurodevelopmental outcomesMean maternal ageInfants of mothersTrimester of exposureInfant gestational ageCross-sectional studyMode of deliveryNon-Hispanic ethnicityClinical features of neonatal COVID-19
Galderisi A, Lista G, Cavigioli F, Trevisanuto D. Clinical features of neonatal COVID-19. Seminars In Fetal And Neonatal Medicine 2023, 28: 101430. PMID: 37005209, PMCID: PMC10036147, DOI: 10.1016/j.siny.2023.101430.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAgedChildChinaCOVID-19FamilyFemaleHumansInfant, NewbornInfectious Disease Transmission, VerticalPandemicsPregnancyPregnancy Complications, InfectiousSARS-CoV-2ConceptsSARS-CoV-2 infectionClinical featuresNeonatal COVID-19Infected mothersHealthy newbornsPsychological health problemsEfforts of cliniciansEpidemiological dataHealth problemsAge groupsInfectionFirst dayHealthcare systemCOVID-19COVID-19 pandemicNewbornsDifferential effectsEntire populationAdditional burdenComorbiditiesPandemicComplicationsNeonatesCliniciansMassive research effort
2022
COVID-19 & differential effects in twins: Insights from Placenta Pathology
Moriarty K, Yu M, Hussain N, Zgutka K, Sanders MM, Harigopal M, Wang J, Wang X, Hui P, Liu C, Sink D, Shields A. COVID-19 & differential effects in twins: Insights from Placenta Pathology. Placenta 2022, 124: 62-66. PMID: 35640456, PMCID: PMC9121647, DOI: 10.1016/j.placenta.2022.05.014.Peer-Reviewed Original ResearchMeSH KeywordsAngiotensin-Converting Enzyme 2COVID-19FemaleHumansInfectious Disease Transmission, VerticalMalePlacentaPregnancyPregnancy Complications, InfectiousSARS-CoV-2ConceptsSARS-CoV-2Perinatal lossCOVID-19Adverse pregnancy outcomesMaternal-fetal interfaceTime of infectionDifferential effectsPregnancy outcomesPremature deliveryFetal interfaceGestational agePlacenta pathologyTwin pregnanciesMembranous expressionFemale fetusesFetal sexViral detection methodsViral receptorsFemale twinsTissue resultsPregnancyPlacentaTask ForceSuccumbedFetusesUnequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil
Aromolaran A, Araujo K, Ladines-Lim JB, Nery N, do Rosário MS, Rastely VN, Archanjo G, Daltro D, da Silveira Carvalho G, Pimentel K, de Almeida JRM, de Siqueira IC, Ribeiro HC, Oliveira-Filho J, de Oliveira D, Henriques DF, Rodrigues SG, da Costa Vasconcelos P, de Almeida ARP, Sacramento GA, Cruz JS, Sarno M, de Paula Freitas B, Mattos A, Khouri R, Reis MG, Ko AI, Costa F. Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal Of Infectious Diseases 2022, 120: 201-204. PMID: 35470025, PMCID: PMC9119857, DOI: 10.1016/j.ijid.2022.04.030.Peer-Reviewed Original ResearchMeSH KeywordsBrazilDelivery of Health CareFemaleHumansInfantMicrocephalyPregnancyPregnancy Complications, InfectiousZika VirusZika Virus InfectionConceptsZIKV exposurePregnant womenSocioeconomic statusRelative disease burdenCongenital Zika syndromeZika virus epidemicLow socioeconomic statusZika syndromeClinical presentationDisease burdenSimilar prevalenceSerologic dataDifferent socioeconomic statusS HospitalHospitalLarge hospitalsMicrocephalyStudy centersVirus epidemicWomenPositive associationInfantsUnequal burdenHigh rateExposure rate
2021
Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 : A Repeated Cross-Sectional Study.
Holstein R, Dawood FS, O'Halloran A, Cummings C, Ujamaa D, Daily Kirley P, Yousey-Hindes K, Fawcett E, Monroe ML, Kim S, Lynfield R, McMullen C, Muse A, Bennett NM, Billing LM, Sutton M, Thomas A, Talbot HK, Schaffner W, Risk I, Reed C, Garg S. Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 : A Repeated Cross-Sectional Study. Annals Of Internal Medicine 2021, 175: 149-158. PMID: 34958603, DOI: 10.7326/m21-3668.Peer-Reviewed Original ResearchMeSH KeywordsAdultCross-Sectional StudiesFemaleHospital MortalityHospitalizationHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanPregnancyPregnancy Complications, InfectiousPregnant PeopleConceptsInfluenza-associated outcomesPregnant womenCross-sectional studyFetal outcomesHospital dischargeInfluenza seasonMechanical ventilationInfluenza Hospitalization Surveillance NetworkIntensive care unit admissionMedical chart abstractionRepeated cross-sectional studySevere maternal outcomesCare unit admissionLaboratory-confirmed influenzaReproductive-aged womenHospitalized pregnant womenInfluenza A H1N1Multivariable logistic regressionHigh-priority target groupUnit admissionHospital deathICU admissionMaternal outcomesChart abstractionClinical characteristicsHigh HIV Detection in a Tertiary Facility in Liberia: Implications and Opportunities
Ogbuagu O, Wachekwa I, Yasin F, Nuta C, Donato S, Toomey J, Adeiza M, Barakat LA. High HIV Detection in a Tertiary Facility in Liberia: Implications and Opportunities. Annals Of Global Health 2021, 87: 117. PMID: 34900617, PMCID: PMC8622250, DOI: 10.5334/aogh.3243.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildFemaleHIV InfectionsHumansLiberiaPregnancyPregnancy Complications, InfectiousPrevalenceRetrospective StudiesYoung AdultConceptsHIV testing dataNon-pregnant individualsHIV detection rateTertiary facilityPrevention interventionsJohn F. Kennedy Medical CenterHospital-based retrospective analysisSignificant public health challengeStudy periodAnnual diagnosis ratePre-exposure prophylaxisPositive HIV testLarge tertiary hospitalCase detection ratePublic health challengeYears of ageNational prevalence estimatesDetection rateHIV/AIDSAntenatal clinicHIV testHIV testingTertiary hospitalPregnant womenUNAIDS 95Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly
Ticona J, Nery N, Doss-Gollin S, Gambrah C, Lessa M, Rastely-Júnior V, Matos A, de Paula Freitas B, Borja A, Wunder EA, Ballalai V, Vieira C, Cruz JS, de Oliveira D, Araujo DB, Oliveira DB, Maeda D, Mendes EA, Soares C, Durigon EL, de Souza Ferreira LC, Belfort R, Almeida A, Oliveira-Filho J, Reis MG, Ko AI, Costa F. Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLOS ONE 2021, 16: e0256444. PMID: 34525107, PMCID: PMC8443077, DOI: 10.1371/journal.pone.0256444.Peer-Reviewed Original ResearchMeSH KeywordsBrazilCephalometryChild, PreschoolDevelopmental DisabilitiesFemaleHumansInfantInfant, NewbornMaleMicrocephalyNeurologic ExaminationPregnancyPregnancy Complications, InfectiousZika VirusZika Virus InfectionConceptsCongenital Zika syndromeHammersmith Infant Neurological ExaminationHINE scoresZika syndromeHead circumferenceBayley-IIILong-term outcomesGreater head circumferenceSevere developmental delayYears of ageSevere neurodevelopmental delayToddler neurodevelopmentNeurological evaluationMedian ageNeurodevelopmental outcomesNeurological examinationMultivariable analysisNeurodevelopmental assessmentOutpatient clinicNeurodevelopmental evaluationNeurodevelopmental delayBayley ScalesNeurodevelopmental profileSevere microcephalyMild delayTreatment and prevention of viral hepatitis in pregnancy
Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Treatment and prevention of viral hepatitis in pregnancy. American Journal Of Obstetrics And Gynecology 2021, 226: 335-346. PMID: 34516961, PMCID: PMC8907340, DOI: 10.1016/j.ajog.2021.09.002.Peer-Reviewed Original ResearchConceptsHepatitis BViral hepatitisHepatitis AHepatitis CAntiviral therapyPregnant womenVertical transmissionImmunoglobulin GActive hepatitis BBirth dose vaccineChronic viral hepatitisHigh clinical suspicionBlood-borne transmissionElevated viral loadRisk of acquisitionVertical transmission riskMedical history reviewTenofovir disoproxil fumarateAcquisition of infectionFecal-oral transmissionRoutine prenatal screeningRoute of infectionHerpes simplex virusVaccine seriesCesarean deliveryDiagnosis of dengue fever in a patient with early pregnancy loss
Adjei NN, Lynn AY, Topran E, Adeyemo OO. Diagnosis of dengue fever in a patient with early pregnancy loss. BMJ Case Reports 2021, 14: e243968. PMID: 34404662, PMCID: PMC8375744, DOI: 10.1136/bcr-2021-243968.Peer-Reviewed Original ResearchMeSH KeywordsAbortion, SpontaneousAnimalsDengueFemaleHumansInfant, NewbornPregnancyPregnancy Complications, InfectiousPremature BirthTravelConceptsInfluenza-like illnessEarly pregnancy lossConsistent clinical evidenceHistory of travelMosquito-borne virusDengue-endemic areasAbdominal crampingDengue serologyOrbital painVaginal bleedingMultiparous womenPreterm birthWeeks' gestationNeonatal deathClinical evidenceIntravenous fluidsPregnant womenAdverse outcomesPregnancy lossDengue feverDengueFeverGestationMiscarriageWomen
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply